JLL Partners Joins Medical Industry Veteran In $100M JV
Law360 (March 10, 2020, 4:04 PM EDT) -- Private equity shop JLL Partners said Tuesday it has joined forces with a biomedical industry veteran in a $100 million joint venture focused on developing materials for medical devices and procedures.
Renovo Health Inc., as the partnership is called, will focus on materials technologies that can support the medical industry. JLL, a middle-market private equity firm based in New York, said its initial commitment of $100 million would capitalize the venture and fund future acquisitions and growth.
The other venture partner, Bart Doedens, is the former CEO of medical device company Collagen Matrix and previously helped lead surgical products company Biomet...
Stay ahead of the curve
In the legal profession, information is the key to success. You have to know what’s happening with clients, competitors, practice areas, and industries. Law360 provides the intelligence you need to remain an expert and beat the competition.
Access to case data within articles (numbers, filings, courts, nature of suit, and more.)
Access to attached documents such as briefs, petitions, complaints, decisions, motions, etc.
Create custom alerts for specific article and case topics and so much more!